Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
123.64
+2.14 (1.76%)
Aug 21, 2026, 11:30 AM EDT - Market open
Kymera Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $140 | Buy | Maintains | $140 | +13.23% | Aug 20, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $132 | Buy | Maintains | $132 | +6.76% | Aug 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $120 → $121 | Buy | Maintains | $120 → $121 | -2.14% | Aug 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $125 → $123 | Buy | Reiterates | $125 → $123 | -0.52% | Aug 7, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $116 | Buy | Reiterates | $116 | -6.18% | Aug 7, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $119 → $135 | Buy | Reiterates | $119 → $135 | +9.19% | Aug 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $129 | Buy | Reiterates | $129 | +4.34% | Aug 6, 2026 |
| UBS | UBS | Buy Maintains $128 | Buy | Maintains | $128 | +3.53% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.